drugset / Trial / NCT02151253
Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
RandomizedCrossoverTriple-blindTreatment
Summary
The objective of the study is to evaluate armodafinil as a wakefulness-promoting therapy as a means of improving residual daytime sleepiness in patients with treated nocturia.
Timeline
- Start
- 2011-05
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Armodafinil | Small molecule | 50 mg | Oral |
| Subject | Armodafinil | Small molecule | 150 mg | Oral |
| Subject | Armodafinil | Small molecule | 250 mg | Oral |